Dose-dependency of life span prolongation of F344/DuCrj rats injected with (-)deprenyl

Biogerontology

Volumn 6, Issue 5, 2005, Pages 297-302

  Kitani, K ^a   Kanai, S ^b   Miyasaka, K ^b   Carrillo, M C ^c   Ivy, G O ^d  

^a NATIONAL CENTER FOR GERIATRICS AND GERONTOLOGY   (Japan)

^b TOKYO METROPOLITAN INSTITUTE OF GERONTOLOGY   (Japan)

^c UNIVERSIDAD NACIONAL DE ROSARIO   (Argentina)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

( )deprenyl; Antioxidant enzymes; F344 male and female rats; Optimal dose range; Specific pathogen free rats; Survival prolongation

Indexed keywords

SELEGILINE; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; FEMALE; LIFESPAN; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RAT STRAIN; SEX DIFFERENCE; STATISTICAL SIGNIFICANCE; STUDENT T TEST; SURVIVAL TIME;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; INJECTIONS, SUBCUTANEOUS; LONGEVITY; MALE; MONOAMINE OXIDASE INHIBITORS; RATS; RATS, INBRED F344; SELEGILINE; TIME FACTORS;

EID: 32044469877     PISSN: 13895729     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10522-005-4804-4     Document Type: Article

References (18)

1. PC Bickford CE Adams SJ Boyson P Curella GA Gerhardt C Heron GO Ivy AMLY Lin MP Murphy K Poth DR Wallace DA Young NR Zahniser GM Rose 1997 Long-term treatment of male F344 rats with deprenyl: Assessment of effects on longevity, behavior, and brain function Neurobiol Aging 18 309-318 10.1016/S0197-4580(97)80313-2 9263197 1:CAS:528:DyaK2sXls1Ont7s%3D
2. EJ Calabrese LA Baldwin 2002 Defining hormesis Hum Exp Toxicol 21 91-97 12102503 1:CAS:528:DC%2BD38XlsF2hsr4%3D
3. MC Carrillo S Kanai M Nokubo GO Ivy Y Sato K Kitani 1992 Deprenyl increases activities of superoxide dismutase and catalase in striatum but not in hippocampus: The sex and age-related differences in the optimal dose in the rat Exp Neurol 116 286-294 10.1016/ 0014-4886(92)90008-E 1587332 1:CAS:528:DyaK38Xks1arsro%3D
4. MC Carrillo S Kanai Y Sato M Nokubo GO Ivy K Kitani 1993 The optimal dosage of (-)deprenyl for increasing superoxide dismutase activities in several brain regions decreases with age in male Fischer 344 rats Life Sci 52 1925-1934 10.1016/0024-3205(93)90633-E 8505859 1:CAS:528:DyaK3sXks1aqs7k%3D
5. MC Carrillo K Kitani S Kanai Y Sato K Miyasaka GO Ivy 1994 The effect of a long term (6 months) treatment with (-)deprenyl on antioxidant enzyme activities in selective brain regions in old female F-344 rats Biochem Pharmacol 47 1333-1338 10.1016/0006-2952(94)90331-X 8185641 1:CAS:528:DyaK2cXjtFGksr8%3D
6. MC Carrillo S Kanai K Kitani GO Ivy 2000 A high dose of long term treatment with deprenyl loses its effect on antioxidant enzyme activities as well as on survivals of Fischer-344 rats Life Sci 67 2539-2548 11104356 1:CAS:528:DC%2BD3cXnslaisbk%3D
7. IM Gallagher A Clow V Glover 1998 Long term administration of (-)deprenyl increases mortality in male Wistar rats J Neural Transm 52 Suppl 315-320 1:CAS:528:DyaK1cXjtlSjtLs%3D
8. IM Gallagher A Clow P Jenner V Glover 1999 Effect of long-term administration of pergolide and (-)deprenyl on age related decline in hole board activity and antioxidant enzymes in rats Biogenic Amines 15 379-393 1:CAS:528:DyaK1MXksVSqurc%3D
9. K Kitani S Kanai Y Sato M Ohta GO Ivy MC Carrillo 1993 Chronic treatment of (-)deprenyl prolongs the life span of male Fischer 344 rats: Further evidence Life Sci 52 281-288 10.1016/0024-3205(93)90219-S 8423709 1:CAS:528:DyaK3sXlt1eltA%3D%3D
10. K Kitani S Kanai GO Ivy MC Carrillo 1998 Assessing the effects of deprenyl on longevity and antioxidant defences in different animal models Ann NY Acad Sci 854 291-306 9928438 1:CAS:528:DyaK1MXjtVeitQ%3D%3D
11. K Kitani C Minami K Isobe K Maehara S Kanai GO Ivy MC Carrillo 2002a Why (-)deprenyl prolongs survivals of experimental animals: Increase of anti-oxidant enzymes in brain and other body tissues as well as mobilization of various humoral factors may lead to systemic anti-aging effects Mech Ageing Dev 123 1087-1100 1:CAS:528:DC%2BD38XktFOlsbk%3D
12. K Kitani C Minami T Yamamoto S Kanai GO Ivy MC Carrillo 2002b Pharmacological interventions in aging and age-associated disorders. Potentials of propargylamines for human use Ann New York Acad Sci 959 295-307 1:CAS:528:DC%2BD38XktFWqu78%3D
13. J Knoll 1988 The striatal dopamine dependency of life span in male rats: longevity study with (-)deprenyl Mech Ageing Dev 46 237-262 10.1016/ 0047-6374(88)90128-5 3147347 1:CAS:528:DyaL1MXovVOgsQ%3D%3D
14. NW Milgram RJ Racine P Nellis A Mendonca GO Ivy 1990 Maintenance of l-deprenyl prolongs life in aged male rats Life Sci 47 415-420 10.1016/ 0024-3205(90)90299-7 2118586 1:CAS:528:DyaK3cXlsVGhtro%3D
15. M Nokubo 1985 Physical-chemical and biochemical differences in liver plasma membranes in aging F-344 rats J Gerontol 40 409-414 2989354 1:CAS:528:DyaL2MXlslKisrg%3D
16. S ThyagaRajan J Meites SK Auadri 1995 Deprenyl reinitiates estrous cycles, reduces serum prolactin, and decreases the incidence of mammary and pituitary tumors in old acyclic rats Endocrinology 136 1103-1110 10.1210/en.136.3.1103 7867565 1:CAS:528:DyaK2MXjvFCjtrc%3D
17. S ThyagaRajan SY Felten DL Felten 1998 Antitumor effect of l-deprenyl in rats with carcinogen-induced mammary tumors Cancer Lett 123 177-183 10.1016/S0304-3835(97)00431-X 9489486 1:CAS:528:DyaK1cXnt12gsQ%3D%3D
18. S ThyagaRajan SK Quadri 1999 l-deprenyl inhibits tumor growth, reduces serum prolactin, and suppresses brain monoamine metabolism in rats with carcinogen-induced mammary tumors Endocrine 10 225-232 10484286 1:CAS:528:DyaK1MXlt1Olsrc%3D